Cancer Research Technology
Log in Register
Menu
Search
Recombinant Antibodies

Anti-EpCAM, Recombinant [AUA1]

Invented by Prof Walter Bodmer from University of Oxford
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
  • Datasheet
  • Inventor Info
Print

Info

Catalogue Number 152581
Applications ELISA FACS IHC IF
Antigen/Gene or Protein Targets Epithelial Cell Adhesion Molecule (EpCAM, CD326)
Reactivity Human
Relevance AUA1 cross reacts with breast carcinomas, kidney tubules, tonsil crypt epithelium and cells in some serious effusions. This is a good antibody for characterisation of all epithelial cells.
Host Mouse
Immunogen LoVo cell line, a colon carcinoma cell line.
Subclass IgG1
Formulation PBS only
Concentration 1mg/ml
Molecular Weight (kDa) 40
Research Area Cancer, Cell Type or Organelle Marker
Notes Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma.

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Original hybridoma first published in Epenetos et al. 1982. Br J Cancer. 46(1):1-8. PMID: 7104190.

View  

Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.

Europe PMC ID: 7104190

View  

Add a reference

References: 2 entries

Original hybridoma first published in Epenetos et al. 1982. Br J Cancer. 46(1):1-8. PMID: 7104190.

View  

Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.

View  

Add a reference

Inventor Information